secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2021-09-03T23:59:59+00:00
Accession:  0001193125-21-265002
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen extends Cytiva supply agreement for ligand manufacture through 2025
----------------------------------------------------------------------------

- Long-term supply agreement with Cytiva Sweden AB extended through 2025.
- Covers contract manufacture of Cytiva ligands at Repligen's Waltham, MA and Lund, Sweden facilities.
- No financial terms or volume commitments disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312521265002/0001193125-21-265002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312521265002/d168793d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-265002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer